Evidence map›Paper›PMID 28459466›Full record

ArticleOncogene2017

Insulin resistance in vascular endothelial cells promotes intestinal tumour formation.

X Wang, M-F Häring, T Rathjen, S M Lockhart, D Sørensen, S Ussar, L M Rasmussen, M M Bertagnolli, C R Kahn, C Rask-Madsen

Open access · bronzeAbstract read
In one paragraph

Article in Oncogene, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. [Expression of tumor-associated vascular insulin receptor in colorectal cancer and its relationship with tumor pathological features].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2020
    Article
  11. Article
  12. Review
  13. Endothelial cells in colorectal cancer.World journal of gastrointestinal oncology · 2019
    Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 5 countries.

X WangJoslin Diabetes Center and Harvard Medical School, Boston, MA, USA.
M-F HäringJoslin Diabetes Center and Harvard Medical School, Boston, MA, USA.
T RathjenJoslin Diabetes Center and Harvard Medical School, Boston, MA, USA.
S M LockhartJoslin Diabetes Center and Harvard Medical School, Boston, MA, USA.
D SørensenJoslin Diabetes Center and Harvard Medical School, Boston, MA, USA.
S UssarJoslin Diabetes Center and Harvard Medical School, Boston, MA, USA.
L M RasmussenOdense University Hospital, University of Southern Denmark, Odense, Denmark.
M M BertagnolliBrigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
C R KahnJoslin Diabetes Center and Harvard Medical School, Boston, MA, USA.
C Rask-MadsenJoslin Diabetes Center and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-8548-466X
Joslin Diabetes Center · USBrigham and Women's Hospital · USQueen's University Belfast · GBUniversity of Southern Denmark · DK

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
INSULIN RECEPTOR STRUCTURE AND TURNOVERR37DK031036 · NIDDK · JOSLIN DIABETES CENTER · PI KAHN, C RONALD · 2000 to 2019
$12.9M
Insulin Receptor Substrates and Insulin ActionR01DK033201 · NIDDK · JOSLIN DIABETES CENTER · PI KAHN, C RONALD · 1986 to 2016
$10.6M
The Insulin Receptor and Its Signaling MechanismsR01DK031036 · NIDDK · JOSLIN DIABETES CENTER · PI C RONALD KAHN · 1986 to 2026
$4.2M
Endothelial cell insulin and increased intestinal tumor formation in obesityR21CA185196 · NCI · JOSLIN DIABETES CENTER · PI RASK-MADSEN, CHRISTIAN · 2014 to 2015
$396k
Special BD LSRFortessaS10OD021740 · OD · JOSLIN DIABETES CENTER · PI SERWOLD, THOMAS F · 2016 to 2016
$363k
NCI NIH HHS R21 CA185196NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK031036NIDDK NIH HHS R01 DK033201NIDDK NIH HHS R37 DK031036
6 · The paper itself

Abstract

The risk of several cancers, including colorectal cancer, is increased in patients with obesity and type 2 diabetes, conditions characterised by hyperinsulinaemia and insulin resistance. Because hyperinsulinaemia itself is an independent risk factor for cancer development, we examined tissue-specific insulin action in intestinal tumour formation. In vitro, insulin increased proliferation of intestinal tumour epithelial cells by almost two-fold in primary culture of tumour cells from Apc

Indexed as

Insulin ResistanceAnimalsCarcinogenesisColorectal NeoplasmsEndothelial CellsGene Knockdown TechniquesInsulinMiceMice, Inbred C57BLMice, KnockoutReceptor, InsulinSignal TransductionTumor MicroenvironmentVascular Cell Adhesion Molecule-1InsulinReceptor, InsulinVascular Cell Adhesion Molecule-1

Identifiers

PMID28459466
PMCPMC5578899
OpenAlexW2611559744

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.